Julie Grisham, MS

Freelance Science Writer

Recent Blog Posts

Pictured: Marcel van den Brink & Robert Jenq
In the Lab
Monday, March 3, 2014

Research suggests that the presence of a type of bacteria called Blautia, which occurs naturally in the body, may prevent graft-versus-host disease, a potentially fatal side effect of bone marrow and stem cell transplants.

Pictured: Renier Brentjens, Isabelle Rivière & Michel Sadelain
In the Clinic
Thursday, February 20, 2014

A new study evaluating a cell-based immune therapy to treat an aggressive type of leukemia — the largest study of its kind to date — reports that 88 percent of patients responded to the treatment.

Pictured: Diane Reidy
Feature
Wednesday, February 19, 2014

Cycle for Survival, Memorial Sloan Kettering’s nationwide indoor team cycling event, helps support research into rare cancers. Three researchers discuss how these funds benefit their research.

Pictured: Lara Benusis
Ask the Expert
Thursday, January 2, 2014

Lara Benusis, head of Memorial Sloan Kettering’s Exercise and Yoga Program, discusses what cancer patients should know about exercise during and after treatment.

Pictured: Low-dose CT scans
In the Clinic
Thursday, December 26, 2013

The American Society of Clinical Oncology’s annual report on top clinical cancer advances of the year once again features several studies led by Memorial Sloan Kettering researchers.

Pictured: T cells
In the News
Monday, December 23, 2013

Memorial Sloan Kettering researchers have played a major role in cancer immunotherapy research, named “Breakthrough of the Year” by Science magazine.

Pictured: Charles L. Sawyers, William Polkinghorn & Simon Powell
In the Lab
Thursday, December 12, 2013

Laboratory studies have revealed an explanation for why androgen-deprivation therapy makes radiation therapy more effective in the treatment of high-risk prostate cancer.

Pictured: Azeez Farooki
Ask the Expert
Tuesday, November 26, 2013

Memorial Sloan Kettering endocrinologist Azeez Farooki discusses the risk factors associated with diabetes and why cancer treatment may be more complicated for those who are diabetic.

Cancer Care
In the Lab
Wednesday, November 13, 2013

The study of some victims exposed to ionizing radiation from the 1986 Chernobyl nuclear power plant accident is yielding new information about how radiation-induced thyroid cancer develops.

Pictured: Craig Thompson
Event
Monday, November 4, 2013

Memorial Sloan Kettering’s annual seminar exposes high school students and their teachers to cutting-edge scientific research.

Pictured: James E. Rothman, Thomas C. Südhof & Randy W. Schekman
Honor
Monday, October 14, 2013

James Rothman, who receives this year’s Nobel Prize in Physiology or Medicine together with Randy Schekman and Thomas Südhof, conducted more than a decade of his seminal research at Memorial Sloan Kettering.

Pictured: James Fagin
Philanthropy
Friday, September 27, 2013

This year The Society of MSKCC’s Annual Appeal aims to raise funds to support thyroid cancer research.

Pictured: Simon Boulton, Levi Garraway, and DJ Pan
Honor
Monday, September 23, 2013

Memorial Sloan Kettering has named three winners of this year’s Paul Marks Prize for Cancer research, an award that recognizes promising young investigators.

Q&A
Wednesday, September 18, 2013

Memorial Sloan Kettering physician-scientist Charles Sawyers, who serves as president of the American Association for Cancer Research, highlights findings from the group’s new report.

Research
Pictured: Derek Tan
Q&A
Monday, September 16, 2013

In this Q&A, Memorial Sloan Kettering chemist Derek Tan discusses why natural products offer inspiration for the development of new drugs.